Improved targeting of miRNA with antisense oligonucleotides

Nucleic Acids Research

Volumn 34, Issue 8, 2006, Pages 2294-2304

  Davis, Scott ^a   Lollo, Bridget ^a   Freier, Susan ^a   Esau, Christine ^a  

^a ISIS PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; LUCIFERASE; MICRORNA; SMALL INTERFERING RNA; CARBOHYDRATE; PHOSPHATE;

3' UNTRANSLATED REGION; ARTICLE; BINDING AFFINITY; CELL PROLIFERATION; CHEMICAL MODIFICATION; CONTROLLED STUDY; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MISMATCH REPAIR; MOLECULAR MECHANICS; NORTHERN BLOTTING; PRIORITY JOURNAL; RNA DEGRADATION; RNA STABILITY; RNA TRANSCRIPTION; RNA TRANSLATION; BASE MISPAIRING; CHEMISTRY; DRUG ANTAGONISM; HELA CELL; KINETICS; REPORTER GENE; RNA INTERFERENCE;

BASE PAIR MISMATCH; CARBOHYDRATES; GENES, REPORTER; HELA CELLS; HUMANS; KINETICS; MICRORNAS; OLIGONUCLEOTIDES, ANTISENSE; PHOSPHATES; RNA INTERFERENCE;

EID: 33646715590     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkl183     Document Type: Article

References (93)

1. Ambros,V. (2004) The functions of animal microRNAs. Nature, 431, 350-355.
2. Bartel,D.P. (2004) MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell, 116, 281-297.
3. He,L. and Hannon,G.J. (2004) MicroRNAs: Small RNAs with a big role in gene regulation. Nature Rev. Genet., 5, 522-531.
4. Du,T. and Zamore,P.D. (2005) microPrimer: The biogenesis and function of microRNA. Development, 132, 4645-4652.
5. Zhao,Y., Samal,E. and Srivastava,D. (2005) Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature, 436, 214-220.
6. Chen,C.-Z., Li,L., Lodish,H.F. and Bartel,D.P. (2004) MicroRNAs modulate hematopoietic lineage differentiation. Science, 303, 83-87.
7. Calin,G.A., Liu,C.G., Sevignani,C., Ferracin,M., Felli,N., Dumitru,C.D., Shimizu,M., Cimmino,A., Zupo,S., Dono,M. et al. (2004) MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc. Natl Acad. Sci. USA, 101, 11755-11760.
8. Calin,G.A., Sevignani,C., Dumitru,C.D., Hyslop,T., Noch,E., Yendamuri,S., Shimizu,M., Rattan,S., Bullrich,F., Negrini,M. et al. (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl Acad. Sci. USA, 101, 2999-3004.
9. McManus,M.T. (2003) MicroRNAs and cancer. Semin. Cancer Biol., 13, 253-258.
10. Lu,J., Getz,G., Miska,E.A., Alvarez-Saavedra,E., Lamb,J., Peck,D., Sweet-Cordero,A., Ebert,B.L., Mak,R.H., Ferrando,A.A. et al. (2005) MicroRNA expression profiles classify human cancers. Nature, 435, 834-838.
11. Hammond,S.M. (2005) MicroRNAs as oncogenes. Curr. Opin. Genet. Dev., 16, 4-9.
12. Volinia,S., Calin,G.A., Liu,C.G., Ambs,S., Cimmino,A., Petrocca,F., Visone,R., Iorio,M., Roldo,C., Ferracin,M. et al. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl Acad. Sci. USA, 103, 2257-2261.
13. Esau,C., Kang,X., Peralta,E., Hanson,E., Marcusson,E.G., Ravichandran,L.V., Sun,Y., Koo,S., Perera,R.J., Jain,R. et al. (2004) MicroRNA-143 regulates adipocyte differentiation. J. Biol. Chem., 279, 52361-52365.
14. Poy,M.N., Eliasson,L., Krutzfeldt,J., Kuwajima,S., Ma,X., MacDonald,P.E., Pfeffer,S., Tuschl,T., Rajewsky,N., Rorsman,P. et al. (2004) A pancreatic islet-specific microRNA regulates insulin secretion. Nature, 432, 226-230.
15. Krutzfeldt,J., Rajewsky,N., Braich,R., Rajeev,K.G., Tuschl,T., Manoharan,M. and Stoffel,M. (2005) Silencing of microRNAs in vivo with 'antagomirs'. Nature, 438, 685-689.
16. Esau,C., Davis,S., Murray,S.F., Yu,X.X., Pandey,S.K., Pear,M., Watts,L., Booten,S.L., Graham,M., McKay,R. et al. (2006) miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab., 3, 87-98.
17. Lecellier,C.H., Dunoyer,P., Arar,K., Lehmann-Che,J., Eyquem,S., Himber,C., Saib,A. and Voinnet,O. (2005) A cellular microRNA mediates antiviral defense in human cells. Science, 308, 557-560.
18. Jopling,C.L., Yi,M., Lancaster,A.M., Lemon,S.M. and Sarnow,P. (2005) Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science, 309, 1577-1581.
19. Griffiths-Jones,S., Grocock,R.J., van Dongen,S., Bateman,A. and Enright,A.J. (2006) miRBase: MicroRNA sequences, targets and gene nomenclature. Nucleic Acids Res., 34, D140-D144.
20. Shahi,P., Loukianiouk,S., Bohne-Lang,A., Kenzelmann,M., Kuffer,S., Maertens,S., Eils,R., Grone,H.J., Gretz,N. and Brors,B. (2006) Argonaute - a database for gene regulation by mammalian microRNAs. Nucleic Acids Res., 34, D115-D118.
21. Taylor,M.F., Wiederholt,K. and Sverdrup,F. (1999) Antisense oligonucleotides: A systematic high-throughput approach to target validation and gene function determination. Drug. Discov. Today, 4, 562-567.
22. Dean,N.M. (2001) Functional genomics and target validation approaches using antisense oligonucleotide technology. Curr. Opin. Biotechnol., 12, 622-625.
23. Kramer,R. and Cohen,D. (2004) Functional genomics to new drug targets. Nature Rev. Drug Discov., 3, 965-972.
24. Ho,S.P. and Hartig,P.R. (1999) Antisense oligonucleotides for target validation in the CNS. Curr. Opin. Mol. Ther., 1, 336-343.
25. Koller,E., Propp,S., Zhang,H., Zhao,C., Xiao,X., Chang,M., Hirsch,S.A., Shepard,P.J., Koo,S., Murphy,C. et al. (2006) Use of a chemically modified antisense oligonucleotide library to identify and validate Eg5 (kinesin-like 1) as a target for antineoplastic drug development. Cancer Res., 66, 2059-2066.
26. Aza-Blanc,P., Cooper,C.L., Wagner,K., Batalov,S., Deveraux,Q.L. and Cooke,M.P. (2003) Identification of modulators of TRAIL-induced apoptosis via RNAi-based phenotypic screening. Mol. Cell, 12, 627-637.
27. Berns,K., Hijmans,E.M., Mullenders,J., Brummelkamp,T.R., Velds,A., Heimerikx,M., Kerkhoven,R.M., Madiredjo,M., Nijkamp, W., Weigelt,B. et al. (2004) A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature, 428, 431-437.
28. Zheng,L., Liu,J., Batalov,S., Zhou,D., Orth,A., Ding,S. and Schultz,P.G. (2004) An approach to genomewide screens of expressed small interfering RNAs in mammalian cells. Proc. Natl Acad. Sci. USA, 101, 135-140.
29. Leung,R.K. and Whittaker,P.A. (2005) RNA interference: From gene silencing to gene-specific therapeutics. Pharmacol. Ther., 107, 222-239.
30. Kurreck,J. (2004) Antisense and RNA interference approaches to target validation in pain research. Curr. Opin. Drug Discov. Devel., 7, 179-187.
31. Nasevicius,A. and Ekker,S.C. (2000) Effective targeted gene 'knockdown' in zebrafish. Nature Genet., 26, 216-220.
32. Zellweger,T., Miyake,H., Cooper,S., Chi,K., Conklin,B.S., Monia,B.P. and Gleave,M.E. (2001) Antitumor activity of antisense clusterin oligonucleotides is improved in vitro and in vivo by incorporation of 2′-O-(2-methoxy)ethyl chemistry. J. Pharmacol. Exp. Ther., 298, 934-940.
33. Watts,L.M., Manchem,V.P., Leedom,T.A., Rivard,A.L., McKay,R.A., Bao,D., Neroladakis,T., Monia,B.P., Bodenmiller,D.M., Cao,J.X. et al. (2005) Reduction of hepatic and adipose tissue glucocorticoid receptor expression with antisense oligonucleotides improves hyperglycemia and hyperlipidemia in diabetic rodents without causing systemic glucocorticoid antagonism. Diabetes, 54, 1846-1853.
34. Yu,X.X., Murray,S.F., Pandey,S.K., Booten,S.L., Bao,D., Song,X.Z., Kelly,S., Chen,S., McKay,R., Monia,B.P. et al. (2005) Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice. Hepatology, 42, 362-371.
35. Lee,Y., Vassilakos,A., Feng,N., Jin,H., Wang,M., Xiong,K., Wright,J. and Young,A. (2006) GTI-2501, an antisense agent targeting R1, the large subunit of human ribonucleotide reductase, shows potent anti-tumor activity against a variety of tumors. Int. J. Oncol., 28, 469-478.
36. Soutschek,J., Akinc,A., Bramlage,B., Charisse,K., Constien,R., Donoghue,M., Elbashir,S., Geick,A., Hadwiger,P., Harborth,J. et al. (2004) Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature, 432, 173-178.
37. Stepkowski,S.M., Qu,X., Wang,M.E., Tian,L., Chen,W., Wancewicz,E.V., Johnston,J.F., Bennett,C.F. and Monia,B.P. (2000) Inhibition of C-raf expression by antisense oligonucleotides extends heart allograft survival in rats. Transplantation, 70, 656-661.
38. Chi,K.N., Eisenhauer,E., Fazli,L., Jones,E.C., Goldenberg,S.L., Powers,J., Tu,D. and Gleave,M.E. (2005) A phase I pharmacokinetic and pharmacodynamic study of OGX-011, a 2′-methoxyethyl antisense oligonucleotide to clusterin, in patients with localized prostate cancer. J. Natl. Cancer Inst., 97, 1287-1296.
39. Dean,N.M. and Bennett,C.F. (2003) Antisense oligonucleotide-based therapeutics for cancer. Oncogene, 22, 9087-9096.
40. Goodchild,J. (2004) Oligonucleotide therapeutics: 25 years agrowing. Curr. Opin. Mol. Ther., 6, 120-128.
41. Crooke,S.T. (2004) Antisense strategies. Curr. Mol. Med., 4, 465-487.
42. Simoes-Wust,A.P., Hopkins-Donaldson,S., Sigrist,B., Belyanskaya,L., Stahel,R.A. and Zangemeister-Wittke,U. (2004) A functionally improved locked nucleic acid antisense oligonucleotide inhibits Bcl-2 and Bcl-xL expression and facilitates tumor cell apoptosis. Oligonucleotides, 14, 199-209.
43. Da Ros,T., Spalluto,G., Prato,M., Saison-Behmoaras,T., Boutorine,A. and Cacciari,B. (2005) Oligonucleotides and oligonucleotide conjugates: A new approach for cancer treatment. Curr. Med. Chem., 12, 71-88.
44. Frieden,M., Christensen,S.M., Mikkelsen,N.D., Rosenbohm,C., Thrue,C.A., Westergaard,M., Hansen,H.F., Orum,H. and Koch,T. (2003) Expanding the design horizon of antisense oligonucleotides with alpha-L-LNA. Nucleic Acids Res., 31, 6365-6372.
45. Frieden,M., Hansen,H.F. and Koch,T. (2003) Nuclease stability of LNA oligonucleotides and LNA-DNA chimeras. Nucleosides Nucleotides Nucleic Acids, 22, 1041-1043.
46. Monia,B.P., Lesnik,E.A., Gonzalez,C., Lima,W.F., McGee,D., Guinosso,C.J., Kawasaki,A.M., Cook,P.D. and Freier,S.M. (1993) Evaluation of 2′-modified oligonucleotides containing 2′-deoxy gaps as antisense inhibitors of gene expression. J. Biol. Chem., 268, 14514-14522.
47. Cummins,L.L., Owens,S.R., Risen,L.M., Lesnik,E.A., Freier,S.M., McGee,D., Guinosso,C.J. and Cook,P.D. (1995) Characterization of fully 2′-modified oligoribonucleotide hetero- and homoduplex hybridization and nuclease sensitivity. Nucleic Acids Res., 23, 2019-2024.
48. Monia,B.P., Johnston,J.F., Sasmor,H. and Cummins,L.L. (1996) Nuclease resistance and antisense activity of modified oligonucleotides targeted to Ha-ras. J. Biol. Chem., 271, 14533-14540.
49. Altmann,K.H., Dean,N.M., Fabbro,D., Freier,S.M., Geiger,T., Haener,R., Huesken,D., Martin,P., Monia,B.P., Muller,M. et al. (1996) Second generation of antisense oligonucleotides. From nuclease resistance to biological efficacy in animals. Chimia, 50, 168-176.
50. Freier,S.M. and Altmann,K.H. (1997) The ups and downs of nucleic acid duplex stability: Structure-stability studies on chemically-modified DNA:RNA duplexes. Nucleic Acids Res., 25, 4429-4443.
51. Geary,R.S., Watanabe,T.A., Truong,L., Freier,S., Lesnik,E.A., Sioufi,N.B., Sasmor,H., Manoharan,M. and Levin,A.A. (2001) Pharmacokinetic properties of 2′-O-(2-methoxyethyl)-modified oligonucleotide analogs in rats. J. Pharmacol. Exp. Ther., 296, 890-897.
52. Lima,W.F., Nichols,J.G., Wu,H., Prakash,T.P., Migawa,M.T., Wyrzykiewicz,T.K., Bhat,B. and Crooke,S.T. (2004) Structural requirements at the catalytic site of the heteroduplex substrate for human RNase H1 catalysis. J. Biol. Chem., 279, 36317-36326.
53. Henry,S., Stecker,K., Brooks,D., Monteith,D., Conklin,B. and Bennett,C.F. (2000) Chemically modified oligonucleotides exhibit decreased immune stimulation in mice. J. Pharmacol. Exp. Ther., 292, 468-479.
54. Cramer,H. and Pfleiderer,W. (2000) Nucleotides LXIV[1]: Synthesis hydridization and enzymatic degradation studies of 2′-O-methyloligoribonucleotides and 2′-O-methyl/deoxy gapmers. Nucleosides Nucleotides Nucleic Acids, 19, 1765-1777.
55. Sproat,B.S., Lamond,A.I., Beijer,B., Neuner,P. and Ryder,U. (1989) Highly efficient chemical synthesis of 2′-O-methyloligoribonucleotides and tetrabiotinylated derivatives; novel probes that are resistant to degradation by RNA or DNA specific nucleases. Nucleic Acids Res., 17, 3373-3386.
56. Kierzek,E., Ciesielska,A., Pasternak,K., Mathews,D.H., Turner,D.H. and Kierzek,R. (2005) The influence of locked nucleic acid residues on the thermodynamic properties of 2′-O-methyl RNA/RNA heteroduplexes. Nucleic Acids Res., 33, 5082-5093.
57. Boutla,A., Delidakis,C. and Tabler,M. (2003) Developmental defects by antisense-mediated inactivation of micro-RNAs 2 and 13 in Drosophila and the identification of putative target genes. Nucleic Acids Res., 31, 4973-4980.
58. Leaman,D., Chen,P.Y., Fak,J., Yalcin,A., Pearce,M., Unnerstall,U., Marks,D.S., Sander,C., Tuschl,T. and Gaul,U. (2005) Antisensemediated depletion reveals essential and specific functions of microRNAs in Drosophila development. Cell, 121, 1097-1108.
59. Hutvagner,G., Simard,M.J., Mello,C.C. and Zamore,P.D. (2004) Sequence-specific inhibition of small RNA function. PLoS Biol., 2, E98.
60. Lee,Y.S., Kim,H.K., Chung,S., Kim,K.S. and Dutta,A. (2005) Depletion of human micro-RNA miR-125b reveals that it is critical for the proliferation of differentiated cells but not for the down-regulation of putative targets during differentiation. J. Biol. Chem., 280, 16635-16641.
61. Cheng,A.M., Byrom,M.W., Shelton,J. and Ford,L.P. (2005) Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res., 33, 1290-1297.
62. Chan,J.A., Krichevsky,A.M. and Kosik,K.S. (2005) MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res., 65, 6029-6033.
63. Schratt,G.M., Tuebing,F., Nigh,E.A., Kane,C.G., Sabatini,M.E., Kiebler,M. and Greenberg,M.E. (2006) A brain-specific microRNA regulates dendritic spine development. Nature, 439, 283-289.
64. Weiler,J., Hunziker,J. and Hall,J. (2005) Anti-miRNA oligonucleotides (AMOs): Ammunition to target miRNAs implicated in human disease? Gene. Ther., 13, 496-502.
65. Puglisi,J.D. and Tinoco,I.,Jr (1989) Absorbance melting curves of RNA. Meth. Enzymol., 180, 304-325.
66. Petersheim,M. and Turner,D.H. (1983) Base-stacking and base-pairing contributions to helix stability: Thermodynamics of double-helix formation with CCGG, CCGGp, CCGGAp, ACCGGp, CCGGUp, and ACCGGUp. Biochemistry, 22, 256-263.
67. Johnson,S.M., Grosshans,H., Shingara,J., Byrom,M., Jarvis,R., Cheng,A., Labourier,E., Reinert,K.L., Brown,D. and Slack,F.J. (2005) RAS is regulated by the let-7 microRNA family. Cell, 120, 635-647.
68. Cimmino,A., Calin,G.A., Fabbri,M., Iorio,M.V., Ferracin,M., Shimizu,M., Wojcik,S.E., Aqeilan,R.I., Zupo,S., Dono,M. et al. (2005) miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl Acad. Sci. USA, 102, 13944-13949.
69. O'Donnell,K.A., Wentzel,E.A., Zeller,K.I., Dang,C.V. and Mendell,J.T. (2005) c-Myc-regulated microRNAs modulate E2F1 expression. Nature, 435, 839-843.
70. Lim,L.P., Lau,N.C., Garrett-Engele,P., Grimson,A., Schelter,J.M., Castle,J., Bartel,D.P., Linsley,P.S. and Johnson,J.M. (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature, 433, 769-773.
71. Lewis,B.P., Burge,C.B. and Bartel,D.P. (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes and microRNA targets. Cell, 120, 15-20.
72. Brennecke,J., Hipfner,D.R., Stark,A., Russell,R.B. and Cohen,S.M. (2003) Bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell, 113, 25-36.
73. Mansfield,J., Harfe,B.D., Nissen,R., Obenauer,J., Srineel,J., Chaudhuri,A., Farzan-Kashani,R., Zuker,M., Pasquinelli,A.E., Ruvkun,G. et al. (2004) MicroRNA-responsive 'sensor' transgenes uncover Hox-like and othere developmentally regulated patterns of vertebrate microRNA expression. Nature Genet., 36, 1076-1083.
74. Meister,G., Landthaler,M., Dorsett,Y. and Tuschl,T. (2004) Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing. RNA, 10, 544-550.
75. Zeng,Y., Yi,R. and Cullen,B.R. (2003) MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms. Proc. Natl Acad. Sci. USA, 100, 9779-9784.
76. Baker,B.F., Lot,S.S., Condon,T.P., Cheng-Flournoy,S., Lesnik,E.A., Sasmor,H.M. and Bennett,C.F. (1997) 2′-O-(2-Methoxy)ethyl-modified anti-intercellular adhesion molecule 1 (ICAM-1) oligonucleotides selectively increase the ICAM-1 mRNA level and inhibit formation of the ICAM-1 translation initiation complex in human umbilical vein endothelial cells. J. Biol. Chem., 272, 11994-12000.
77. Stein,C.A., Subasinghe,C., Shinozuka,K. and Cohen,J.S. (1988) Physicochemical properties of phosphorothioate oligodeoxynucleotides. Nucleic Acids Res., 16, 3209-3221.
78. Kawasaki,A.M., Casper,M.D., Freier,S.M., Lesnik,E.A., Zounes,M.C., Cummins,L.L., Gonzalez,C. and Cook,P.D. (1993) Uniformly modified 2′-deoxy-2′-fluoro phosphorothioate oligonucleotides as nuclease-resistant antisense compounds with high affinity and specificity for RNA targets. J. Med. Chem., 36, 831-841.
79. McKay,R.A., Miraglia,L.J., Cummins,L.L., Owens,S.R., Sasmor,H. and Dean,N.M. (1999) Characterization of a potent and specific class of antisense oligonucleotide inhibitor of human protein kinase C-alpha expression. J. Biol. Chem., 274, 1715-1722.
80. Hoke,G.D., Draper,K., Freier,S.M., Gonzalez,C., Driver,V.B., Zounes,M.C. and Ecker,D.J. (1991) Effects of phosphorothioate capping on antisense oligonucleotide stability, hybridization and antiviral efficacy versus herpes simplex virus infection. Nucleic Acids Res., 19, 5743-5748.
81. Gregory,R.I., Chendrimada,T.P., Cooch,N. and Shiekhattar,R. (2005) Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell, 123, 631-640.
82. Maniataki,E. and Mourelatos,Z. (2005) A human, ATP-independent, RISC assembly machine fueled by pre-miRNA. Genes Dev., 19, 2979-2990.
83. Matranga,C., Tomari,Y., Shin,C., Bartel,D. and Zamore,P. (2005) Passenger-strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexes. Cell, 123, 607-620.
84. Miyoshi,K., Tsukumo,H., Nagami,T., Siomi,H. and Siomi,M.C. (2005) Slicer function of Drosophila Argonautes and its involvement in RISC formation. Genes Dev., 19, 2837-2848.
85. Chendrimada,T.P., Gregory,R.I., Kumaraswamy,E., Norman,J., Cooch,N., Nishikura,K. and Shiekhattar,R. (2005) TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature, 436, 740-744.
86. Parker,J.S., Roe,S.M. and Barford,D. (2005) Structural insights into mRNA recognition from a PIWI domain-siRNA guide complex. Nature, 434, 663-666.
87. Ma,J.B., Yuan,Y.R., Meister,G., Pei,Y., Tuschl,T. and Patel,D.J. (2005) Structural basis for 5′-end-specific recognition of guide RNA by the A. fulgidus Piwi protein. Nature, 434, 666-670.
88. Lee,Y., Hur,I., Park,S.Y., Kim,Y.K., Suh,M.R. and Kim,V.N. (2006) The role of PACT in the RNA silencing pathway. EMBO. J., 25, 522-532.
89. Lee,Y., Ahn,C., Han,J., Choi,H., Kim,J., Yim,J., Lee,J., Provost,P., Radmark,O., Kim,S. et al. (2003) The nuclear RNase III Drosha initiates microRNA processing. Nature, 425, 415-419.
90. Lund,E., Guttinger,S., Calado,A., Dahlberg,J.E. and Kutay,U. (2004) Nuclear export of microRNA precursors. Science, 303, 95-98.
91. Yi,R., Qin,Y., Macara,I.G. and Cullen,B.R. (2003) Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev., 17, 3011-3016.
92. Vickers,T.A., Wyatt,J.R. and Freier,S.M. (2000) Effects of RNA secondary structure on cellular antisense activity. Nucleic Acids Res., 28, 1340-1347.
93. Prasanth,K.V., Prasanth,S.G., Xuan,Z., Hearn,S., Freier,S.M., Bennett,C.F., Zhang,M.Q. and Spector,D.L. (2005) Regulating gene expression through RNA nuclear retention. Cell, 123, 249-263.